Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a Results Posted entry on 2026-02-13 detailing DLT incidence, PFS, adverse events, ORR/OS, and related time frames, and uploaded associated documents (Informed Consent Form, Protocol and SAP).
    Difference
    2%
    Check dated 2026-02-19T05:29:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1; these are minor site version updates and do not affect the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:30:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1, a minor update that does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:54:19.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the lowercase/older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has removed core documents and data-sharing sections, including the Statistical Analysis Plan, Study Protocol, IPD Sharing Information, and related data access criteria.
    Difference
    18%
    Check dated 2026-01-21T06:13:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T03:22:36.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.